These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7059633)

  • 1. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
    Lipcsey A
    Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
    Arató M; Bagdy G; Perényi A
    Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
    [No Abstract]   [Full Text] [Related]  

  • 8. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia].
    Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG
    Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation among plasma dopamine beta-hydroxylase, monoamine oxidase and Cu++].
    Stagni S; Mello P; Gualandi S; Guidi M; Illuminati B; Scanabissi E
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1603-6. PubMed ID: 7459081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia.
    Markianos M; Rinieris P; Hatzimanolis J; Stefanis C
    Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma DBH activity: relation to genetic factors in schizophrenia.
    Baron M; Levitt M; Perlman R
    Commun Psychopharmacol; 1980; 4(3):197-202. PubMed ID: 7226750
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders.
    Wetterberg L; Aberg H; Ross SB; Frödén O
    Scand J Clin Lab Invest; 1972 Nov; 30(3):283-9. PubMed ID: 4264461
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics.
    Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z
    Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Serum dopamine beta hydroxylase activities in the insulin test].
    Okada F; Yamashita I; Suwa N; Kunita H; Hata S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):643. PubMed ID: 4476636
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in dopamine-beta-hydroxylase, and copper, and catecholamine concentrations in human plasma with physical exercise.
    Ohno H; Yahata T; Hirata F; Yamamura K; Doi R; Harada M; Taniguchi N
    J Sports Med Phys Fitness; 1984 Dec; 24(4):315-20. PubMed ID: 6533406
    [No Abstract]   [Full Text] [Related]  

  • 20. Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
    Markianos M; Tripodianakis J
    Biol Psychiatry; 1985 Jan; 20(1):98-101. PubMed ID: 3965042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.